Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty project

Abstract

Overall, primary angioplasty-based care is highly likely to be cost-effective at an assumed threshold of 20,000 pounds per QALY gained. It is more likely to be cost-effective if patients are admitted directly to the cardiac catheter laboratory rather than via other hospital departments, or if transferred from another hospital.